Page last updated: 2024-08-16

resveratrol and Intraocular Pressure

resveratrol has been researched along with Intraocular Pressure in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Cao, K; Fang, Y; Ishida, T; Li, X; Nagaoka, N; Ohno-Matsui, K; Shinohara, K; Yoshida, T1
Kandasamy, R; Muthusamy, S; Natesan, S; Palanichamy, R; Pandian, S; Ponnusamy, C1
Feng, Y; Niu, W; Wang, J; Wang, Y; Xiang, D; Yuan, F; Zhang, X1
Cengiz, A; Emre, E; Kürşat Yıldız, D; Pirhan, D; Yüksel, N1
Agarwal, P; Agarwal, R; Ismail, NM; Kapitonova, MY; Khalid, Z; Kutty, MK; Razali, N; Smirnov, A; Tripathy, M1
Alarma-Estrany, P; Crooke, A; Pintor, J1
Chao, FP; Chao, HM; Chen, MM; Liu, JH; Liu, XQ; Pan, WH; Wu, BJ; Zhang, XM1

Other Studies

7 other study(ies) available for resveratrol and Intraocular Pressure

ArticleYear
Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension.
    Investigative ophthalmology & visual science, 2020, 03-09, Volume: 61, Issue:3

    Topics: Acetylation; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cell Death; Cells, Cultured; Cytoprotection; Disease Models, Animal; Drug Evaluation, Preclinical; Intraocular Pressure; Intravitreal Injections; Male; Mice, Inbred C57BL; Microspheres; Ocular Hypertension; Reactive Oxygen Species; Resveratrol; Retinal Ganglion Cells; Sirtuin 1; Tumor Suppressor Protein p53

2020
Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    International journal of biological macromolecules, 2017, Volume: 104, Issue:Pt B

    Topics: Animals; Antioxidants; Chickens; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Intraocular Pressure; Nanoparticles; Osmolar Concentration; Particle Size; Polyethylene Glycols; Quercetin; Rabbits; Resveratrol; Spectroscopy, Fourier Transform Infrared; Stilbenes

2017
Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model.
    Life sciences, 2018, Aug-15, Volume: 207

    Topics: Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Intraocular Pressure; Male; Mitochondria; Mitochondrial Diseases; Ocular Hypertension; Organelle Biogenesis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Retina; Stilbenes

2018
Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma.
    Current eye research, 2016, Volume: 41, Issue:1

    Topics: Animals; Antioxidants; Cell Count; Cell Survival; Disease Models, Animal; Drug Therapy, Combination; Glaucoma; Injections, Intraperitoneal; Intraocular Pressure; Male; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; Retinal Ganglion Cells; Riluzole; Stilbenes; Tonometry, Ocular

2016
Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats.
    Experimental eye research, 2016, Volume: 143

    Topics: Administration, Topical; Animals; Antioxidants; Aqueous Humor; Cell Count; Disease Models, Animal; Female; Glucocorticoids; Intraocular Pressure; Male; Matrix Metalloproteinase 2; Ocular Hypertension; Ophthalmic Solutions; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Retina; Retinal Ganglion Cells; Stilbenes; Tonometry, Ocular; Trabecular Meshwork

2016
5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit.
    Journal of pineal research, 2009, Volume: 47, Issue:2

    Topics: Amino Acid Sequence; Animals; Base Sequence; Chloroquine; Ciliary Body; Cornea; Humans; Immunohistochemistry; Intraocular Pressure; Molecular Sequence Data; Quinone Reductases; Rabbits; Receptors, Melatonin; Resveratrol; RNA Interference; RNA, Small Interfering; Sequence Alignment; Stilbenes; Tryptamines; Vitamin K 3

2009
Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:1

    Topics: Animals; Dose-Response Relationship, Drug; Down-Regulation; Electroretinography; Heme Oxygenase-1; Intraocular Pressure; Matrix Metalloproteinase 9; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Resveratrol; Retina; Retinal Vessels; RNA, Messenger; Stilbenes; Thy-1 Antigens; Up-Regulation; Vimentin

2013